CAMP4 Therapeutics Corporation enterprise value

The Enterprise Value as of November 2026 (TTM) for CAMP4 Therapeutics Corporation (CAMP) is 157.47M

According to CAMP4 Therapeutics Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 157.47M. This represents a change of 18.40% compared to the average of 133.00M of the last 4 quarters.

CAMP4 Therapeutics Corporation (CAMP) Historical Enterprise Value (quarterly & annually)

How has CAMP Enterprise Value performed in the past?

The mean historical Enterprise Value of CAMP4 Therapeutics Corporation over the last ten years is 76.14M. The current 157.47M Enterprise Value has changed 106.83% with respect to the historical average. Over the past ten years (40 quarters), CAMP's Enterprise Value was at its highest in in the September 2024 quarter at 216.02M. The Enterprise Value was at its lowest in in the September 2025 quarter at -5384002.00.

CAMP4 Therapeutics Corporation (CAMP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CAMP4 Therapeutics Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CAMP4 Therapeutics Corporation (CAMP) Average Enterprise Value

How has CAMP Enterprise Value performed in the past?

The current Enterprise Value of CAMP4 Therapeutics Corporation (CAMP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

CAMP4 Therapeutics Corporation (CAMP) Enterprise Value vs. Peers

How is CAMP’s Enterprise Value compared to its peers?

CAMP4 Therapeutics Corporation’s Enterprise Value is greater than Unicycive Therapeutics, Inc. (49.21M), greater than Repare Therapeutics Inc. (41.75M), greater than Vaxart, Inc. (61.35M), greater than Biomea Fusion, Inc. (12.27M), greater than MindWalk Holdings Corp. (69.58M), greater than Quince Therapeutics, Inc. (-83607980.00), less than ALX Oncology Holdings Inc. (169.54M), greater than Acrivon Therapeutics, Inc. Common Stock (31.83M), greater than PMV Pharmaceuticals, Inc. (60.28M), greater than aTyr Pharma, Inc. (10.76M),

Build a custom stock screener for CAMP4 Therapeutics Corporation (CAMP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CAMP4 Therapeutics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CAMP4 Therapeutics Corporation (CAMP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CAMP4 Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.